Physician
Internal Medicine
Dr. Brady L. Stein, MD
|
|
Give Review
Dr. Brady L. Stein works in the field of Internal Medicine. He went to medical school at Emory University School of Medicine. Emory University School of Medicine is ranked 23/42 in Research/PrimaryCare. He has 1 awards "Meaningful Use Stage 1 Certification". Brady L. Stein is a published physician. He has 18 papers published. The most current publication "Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms." Brady Stein is registered with Medicare.
Publications
- Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms.
- Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F.
- Bleeding complications in BCR-ABL negative myeloproliferative neoplasms: prevalence, type, and risk factors in a single-center cohort.
- Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition.
- Polycythemia vera disease burden: contributing factors, impact on quality of life, and emerging treatment options.
- AKT is a therapeutic target in myeloproliferative neoplasms.
- Could hypoxia increase the prevalence of thrombotic complications in polycythemia vera?
- Age-related differences in disease characteristics and clinical outcomes in polycythemia vera.
- Janus kinase inhibitors: an update on the progress and promise of targeted therapy in the myeloproliferative neoplasms.
- Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycy...
- Gender and Vascular Complications in the JAK2 V617F-Positive Myeloproliferative Neoplasms.
- Primary myelofibrosis and the myeloproliferative neoplasms: the role of individual variation.
- Detection of exon 12 Mutations in the JAK2 gene: enhanced analytical sensitivity using clamped PCR and nucleotide sequencing.
- Clinical Use of Anti-Xa Monitoring in Malignancy-Associated Thrombosis.
- Disease burden at the progenitor level is a feature of primary myelofibrosis: a multivariable analysis of 164 JAK2 V617F-positive myeloproliferative neoplasm patients.
- Advanced age and prognosis in chronic myeloid leukemia in the era of tyrosine kinase inhibitors.
- Sex differences in the JAK2 V617F allele burden in chronic myeloproliferative disorders.
Schools
Emory University
Doctors Specialties
- Hematology
- Internal Medicine
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
Education
-
Johns Hopkins University -
Emory University School of Medicine
Hospital
-
Northwestern Memorial Hospital -
Lurie Children's Hospital of Chicago
Helpful Reviews
Similar Doctors
|
|
Dr. Albene E. Kokocinski, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rudolf K. Kumapley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harold H. Jaimes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Solomon S. Adler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fred Rosen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Parameswaran Venugopal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kamila I. Cisak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Selina L. Chow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nilay A. Shah, MD |
|
|
Dr. Jesse A. Soodalter, MD
This Doctor is OpenDoctor Recommended.
|